Germ cell 1 spermatogonial (GC-1spg) cells are multipotent progenitor cells. We 31 previously confirmed that bone morphogenetic protein (BMP) 9 is among the most 32 osteogenic BMPs. However, whether GC-1spg cells are driven toward osteogenic 33 differentiation under proper stimuli is uncertain. Additionally, the molecular 34 mechanism of BMP9 remains unclear. In the present study, we aimed to determine 35 whether BMP9 can induce osteogenic differentiation of GC-1spg cells. Recombinant 36 adenoviruses were generated by the AdEasy system to regulate the BMP9 expression in 37 GC-1spg cells. We identified osteogenic markers by real-time PCR and staining 38 techniques in vitro. Ectopic ossification assays and histological analysis were also 39 performed to verify the in vivo activity of BMP9. Finally, potential signaling pathways 40 of BMP9 were assessed by transcriptome sequencing and KEGG enrichment analysis.
paraffin. Serial sections were stained with hematoxylin and eosin (H&E, Sigma-Aldrich), 139 Masson's trichrome (Sigma-Aldrich), and alcian blue (Sigma-Aldrich) [17, 27, 38, 53] .
140
Signaling pathway analysis 141 Transcriptome sequencing and KEGG enrichment analysis were performed for BMP9 142 relevant signaling pathway analysis. GC-1spg cells were seeded in 100 mm culture dishes 143 and infected with Ad-BMP9 or Ad-GFP. 157 We first tested our recombinant adenoviruses and observed that Ad-BMP9 upregulated 158 BMP9 expression ( Fig. 1A-B ). GFP expression was also present in Ad-BMP9-infected cells 9 159 ( Fig. 1A-B ). BMP9 is a potent osteogenesis inducer. Therefore, we next tested BMP9 160 function in GC-1spg cells. Several osteogenic differentiation markers, including Runx2, 161 osteocalcin (OCN), osteopontin (OPN), and Sox9 [17, 38, 53] , were upregulated by BMP9 162 (Fig. 1C ). We then examined the early osteogenic markers ALP [17, 62, 63] and mineral node 163 formation. ALP activity was analyzed by histochemical staining. Our results showed that 164 BMP9 overexpression increased early osteogenesis differentiation, indicated by ALP activity 165 in GC-1spg cells (Fig. 1D ). Alizarin Red S staining was then used to identify mineral nodes.
Results

156
BMP9 upregulates osteogenic differentiation markers in vitro
166
Similarly, BMP9 overexpression visibly increased mineral nodule formation in vitro ( Fig.   167 1E). These results suggest that BMP9 regulates osteogenic differentiation of GC-1spg cells. 185 To verify our in vitro results that show exogenous BMP9-induced GC-1spg cell osteogenesis, 186 we performed ectopic ossification experiments. Using our previously established stem cell 187 implantation assay [14, 17, 38, 53] , we detected injection-site masses in both BMP9 and GFP 188 groups. Masses in the BMP9 group appeared slightly larger than in the GFP group. Micro-CT 189 analysis also showed differences in tissue volume, bone volume, and bone surface area 190 between Ad-BMP9 and Ad-GFP-injected tumors ( Fig. 2 A-B ). were not observed between the two groups using H&E staining, but Masson's trichrome 205 staining revealed more mature cells with increased mineralization from exogenous BMP9 206 expression. Analogously, alcian blue staining also showed the accumulation of chondroid 
BMP9 induces ectopic bone formation in vivo
